Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. [electronic resource]
Producer: 20070305Description: 465-72 p. digitalISSN:- 0022-0795
- Acetylation
- Antigens, Neoplasm -- analysis
- Antineoplastic Agents -- therapeutic use
- Apoptosis
- Carcinoma -- drug therapy
- Caspase 3 -- metabolism
- Cell Cycle -- drug effects
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- DNA Fragmentation
- DNA Topoisomerases, Type II -- analysis
- DNA-Binding Proteins -- analysis
- Doxorubicin -- therapeutic use
- Histone Deacetylase Inhibitors
- Histones -- metabolism
- Humans
- RNA, Messenger -- analysis
- Thyroid Neoplasms -- drug therapy
- Valproic Acid -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.